• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Range Cancer Therapeutics ETF (NQ:CNCR)

9.020 UNCHANGED
Last Price Updated: 4:15 PM EDT, May 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 9.020
Bid (Size) 7.800 (1)
Ask (Size) 19.92 (4)
Prev. Close 9.020
Today's Range 9.020 - 9.020
52wk Range 9.020 - 9.020
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Did CANF Stock Soar 40% In Pre-Market Today? ↗
March 04, 2026
The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint. 
Via Stocktwits
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers ↗
November 10, 2025
Via Stocktwits

Performance

More News

Read More
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments ↗
November 03, 2025
Via Stocktwits
Vor Bio Stock Jumped 19% Today And Retail Investors Are Eyeing A Breakout Rally: Here’s What’s Happening ↗
August 13, 2025
Via Stocktwits
News headline image
3 Top-Ranked ETFs Under $20 For Your Portfolio ↗
June 07, 2024
Via Talk Markets
Topics ETFs
News headline image
5 Market-Beating Sector ETFs Of Q1 ↗
March 27, 2024
Via Talk Markets
Topics ETFs
News headline image
5 Sector ETFs Beating The Market Halfway Through Q1 ↗
February 12, 2024
Via Talk Markets
Topics ETFs
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
March 15, 2023
Via InvestorPlace
News headline image
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023 ↗
January 04, 2023
Via Talk Markets
News headline image
5 ETFs Riding High On The Biotech Comeback ↗
July 09, 2022
Via Talk Markets
News headline image
3 Promising Oncology Stocks To Consider Adding To Your Portfolio ↗
June 14, 2021
Via Talk Markets
News headline image
Best Biotech Stocks & ETFs for mRNA, Gene Editing ↗
April 29, 2021
Via Talk Markets

Frequently Asked Questions

Is Range Cancer Therapeutics ETF publicly traded?
Yes, Range Cancer Therapeutics ETF is publicly traded.
What exchange does Range Cancer Therapeutics ETF trade on?
Range Cancer Therapeutics ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Range Cancer Therapeutics ETF?
The ticker symbol for Range Cancer Therapeutics ETF is CNCR on the Nasdaq Stock Market
What is the current price of Range Cancer Therapeutics ETF?
The current price of Range Cancer Therapeutics ETF is 9.020
When was Range Cancer Therapeutics ETF last traded?
The last trade of Range Cancer Therapeutics ETF was at 05/27/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap